Journals / The Anatolian Journal of Cardiology / 2020 / Cilt: 24 - Sayı: 3

Comparisons of microbiota-generated metabolites in patients with young and elderly acute coronary syndrome

Pages
175–182
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the second model, young ACS was significantly associated with TMAO level (ß=0.230, p=0.035).Conclusion: In this study, we have shown that young ACS was significantly associated with increased TMAO level. (Anatol J Cardiol 2020; 24: 175-82)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acute coronary syndrome (ACS) is a leading cause of death worldwide.
📊
Key Findings & Data:The microbiota and its metabolites have recently become a popular research topic, yet there is still no study that investigated microbiota-generated metabolites as a possible risk factor in young patients with ACS.
💡
Conclusion & Impact:In the second model, young ACS was significantly associated with TMAO level (ß=0.230, p=0.035).Conclusion: In this study, we have shown that young ACS was significantly associated with increased TMAO level. (Anatol J Cardiol 2020; 24: 175-82)
🔬Design:Modeling & Simulation
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Acute coronary syndrome (ACS) is a leading cause of death worldwide. There is great interest in defining the risk factors and under-lying mechanisms of ACS among young people. The microbiota and its metabolites have recently become a popular research topic, yet there is still no study that investigated microbiota-generated metabolites as a possible risk factor in young patients with ACS. In this study, we aimed to investigate the relationship between microbiota-generated metabolites and ACS in young people.Methods: This study included 44 young patients with ACS (<50 years of age), 39 elderly patients with ACS, and 44 patients with normal coronary arteries. Inflammatory parameters and serum trimethylamine N-oxide (TMAO) and choline levels were measured in all patients.Results: Young patients with ACS had significantly higher levels of TMAO and choline compared to the control and elderly ACS groups. Also, elderly patients with ACS had a significantly higher level of TMAO than the control group. Linear regression analysis was performed to determine the independent predictors of TMAO. Two regression models were involved. The first model included young ACS and control groups, while the second model included young and elderly ACS groups. In the first model, we found that young ACS (ß=0.399, p=0.004) and smoking ACS (ß=0.211, p=0.046) were significantly associated with TMAO level. In the second model, young ACS was significantly associated with TMAO level (ß=0.230, p=0.035).Conclusion: In this study, we have shown that young ACS was significantly associated with increased TMAO level. (Anatol J Cardiol 2020; 24: 175-82)

🔖

Cite This Article

TAŞCANOV, M. B., TANRIVERDİ, Z., GÜNGÖREN, F., BEŞLİ, F., ERKUŞ, M. E., KOYUNCU, İ., GÖNEL, A., TAPAR, G. G. (2020). Comparisons of microbiota-generated metabolites in patients with young and elderly acute coronary syndrome. The Anatolian Journal of Cardiology, Cilt: 24 - Sayı: 3, 175–182. https://ajindex.com/articles/365699

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al.; American Heart Association Council on Epide-miology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019; 139: e56-e528
  2. Mack M, Gopal A. Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease. Heart Fail Clin 2016; 12: 1-10
  3. Kim HL, Kim MA, Oh S, Kim M, Yoon HJ, Park SM, et al. Sex Differ-ences in Traditional and Nontraditional Risk Factors for Obstruc-tive Coronary Artery Disease in Stable Symptomatic Patients. J Womens Health (Larchmt) 2019; 28: 212-9
  4. Hajar R. Risk Factors for Coronary Artery Disease: Historical Per-spectives. Heart Views 2017; 18: 109-14
  5. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vadugana-than M, Pandey A, et al. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Cir-culation 2019; 139: 1047-56
  6. Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med 2019; 23: 2343-50
  7. Haghikia A, Li XS, Liman TG, Bledau N, Schmidt D, Zimmermann F, et al. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Relat-ed to Proinflammatory Monocytes. Arterioscler Thromb Vasc Biol 2018; 38: 2225-35
  8. Lautamäki A, Airaksinen KE, Kiviniemi T, Vinco G, Ribichini F, Gunn J, et al. Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study. Atherosclerosis 2014; 235: 483-7
  9. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC Guide-lines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the man-agement of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-77
  10. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. Linee guida ESC 2015 per il trattamento delle sindromi coro-nariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla